QUARTA, SANTINA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.937
AS - Asia 748
EU - Europa 655
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.342
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.934
CN - Cina 419
SG - Singapore 267
IT - Italia 188
SE - Svezia 124
FI - Finlandia 118
DE - Germania 76
RU - Federazione Russa 38
IN - India 30
FR - Francia 29
GB - Regno Unito 25
UA - Ucraina 25
IE - Irlanda 16
VN - Vietnam 16
HK - Hong Kong 10
NL - Olanda 7
BE - Belgio 3
BG - Bulgaria 3
CA - Canada 2
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
EU - Europa 1
JO - Giordania 1
JP - Giappone 1
KZ - Kazakistan 1
MX - Messico 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
Totale 5.342
Salva come PNG Salva come JPEG
Città #
Fairfield 502
Chandler 418
Woodbridge 283
Houston 239
Jacksonville 231
Wilmington 229
Ann Arbor 220
Singapore 217
Ashburn 213
Cambridge 195
Seattle 186
Santa Clara 149
Boardman 131
Padova 97
Princeton 79
Des Moines 72
San Diego 66
Helsinki 64
Nanjing 64
Medford 57
Beijing 55
Dearborn 40
Roxbury 35
New York 28
Shenyang 24
Guangzhou 23
Changsha 21
Hefei 20
Pune 17
Dublin 16
Dong Ket 15
Jinan 15
Jiaxing 14
Nanchang 14
Kunming 13
Hebei 12
Tianjin 11
London 10
Detroit 9
Hong Kong 9
Shanghai 9
Paris 7
Dallas 6
Florence 6
Norwalk 6
Redwood City 6
Frankfurt am Main 5
Ningbo 5
Springfield 5
Zhengzhou 5
Haikou 4
Milan 4
Ogden 4
Pesaro 4
Phoenix 4
Rockville 4
Rome 4
Viareggio 4
Wuhan 4
Los Angeles 3
Prineville 3
Sofia 3
Turin 3
Urbino 3
Venezia 3
Washington 3
Atlanta 2
Brescia 2
Campodarsego 2
Columbus 2
Fossò 2
Fuzhou 2
Gubbio 2
Hangzhou 2
Hanover 2
Kharkiv 2
Legnaro 2
Riese Pio X 2
San Jose 2
Shaoxing 2
Tappahannock 2
Trento 2
Vicenza 2
Vico del Gargano 2
Albignasego 1
Almaty 1
Amman 1
Amsterdam 1
Arezzo 1
Baku 1
Baotou 1
Brooklyn 1
Brussels 1
Charlotte 1
Chengdu 1
Chongqing 1
Edinburgh 1
Findlay 1
Forest City 1
Genoa 1
Totale 4.282
Salva come PNG Salva come JPEG
Nome #
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 191
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting 178
Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes 161
SCCA1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity 155
Biological and clinical implications of HBV infection in peripheral blood mononuclear cells 145
SERPINB3 induces epithelial-mesenchymal transition. 129
SERPINB3, apoptosis and autoimmunity 123
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 120
Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells 119
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 117
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. 113
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 110
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? 108
Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma 107
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 100
Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming 100
Hepatic progenitor cells express SerpinB3 98
Au(III)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells 98
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma 96
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 92
Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett's carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy 92
Low p66shc with high serpinb3 levels favors necroptosis and better survival in hepatocellular carcinoma 88
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 80
Activation of pivotal cell cycle proteins and inhibition of apoptosis by SCCA1 in HepG2 cells 79
Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis 79
Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis 77
HEPATIC PROGENITOR CELLS OVEREXPRESS SERPINB3 IN A MOUSE MODEL OF FULMINANT HEPATITIS 76
SCCA overexpression induces cell proliferation and down-regulation of the adhesion system 74
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 74
Circulating Squamous Cell Carcinoma Antigen-IgM complexes as novel biomarkers for hepatocellular carcinoma 69
Espressione della serpina SCCA in cellule mononucleate di sangue periferico in pazienti con infezione cronica da HCV 65
HPYPOXYA UP-REGULATES SERPINB3 IN HEPATIC CANCER CELLS: A HIF-2a ASSOCIATED EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 64
SQUAMOUS CELL CARCINOMA ANTIGEN (SCCA) ENHANCES LIVER REGENERATION AFTER PARTIAL HEPATECTOMY 64
SERPINB3 modulates TGF-beta expression in chronic liver disease. 62
ESPRESSIONE DELLA SERPINA SCCA IN CELLULE MONONUCLEATE DI SANGUE PERIFERICO IN PAZIENTI CO INFEZIONE CRONICA DA HCV 62
HCC invasiveness induced by SCCA is associated with nuclear beta-catenin accumulation 62
HYPOXIA UP-REGULATES SERPINB3 IN HEPG2 CELLS: A REDOX SENSITIVE EVENT RELATED TOEPITHELIAL TO MESENCHYMAL TRANSITIONAND INVASIVENESS 60
RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA 60
SCCA1-IGM AND SCCA2-IGM COMPARED WITH TOTAL SCCA-IGM FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA 60
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 60
DEREGOLAZIONE DELL’ESPRESSIONE DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) NEI LINFOCITI B IN PAZIENTI INFETTI DA HCV 60
Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: design and biological in vitro data 60
Deregulation of Squamous Cell Carcinoma Antigen (SCCA) expression in B lymphocytes in patients with chronic hepatitis C 58
Biodistribution of Intratracheal, Intranasal, and Intravenous Injections of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles in a Mouse Model for Drug Delivery Studies 57
SCCA EXPRESSION IN PBMCs IN PATIENTS WITH CHRONIC HEPATITIS C 57
HFE, TGF-BETA1 AND SQUAMOUS CELL CARCNOMA ANTIGEN-1 POLYMORPHISMS AND LIVER DISEASE STAGE IN CHRONIC HCV INFECTION 55
Serum SCCA IgM complexes increase over time and HCC development in cirrhotic patients 54
CHARACTERIZATION OF SCCA-1(SERPINB3) ISOFORMS IN HEPATOCELLULAR CARCINOMA 54
OVEREXPRESSION OF SERPINB3 IN HEPATIC PROGENITOR CELLS IN A MOUSE MODEL OF ACUTE LIVER INJURY 53
POLIMORFISMO DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E PROGRESSIONE DELLA MALATTIA EPATICA NELL’INFEZIOE HCV 53
Monitoring SCCA-IgM complex predicts liver disease progression in patients with chronic hepatitis and cirrhosis 53
SERPINB3 PROMUOVE L’INVASIVITA’ CELLULARE 52
Squamous cell carcinoma antigen (SCCA) expression and CD27+ memory B lymphocytes in patients with chronic hepatitis C and systemic lupus erythematosus (SLE) 50
SEX DEPENDENT IL-6 DEREGULATION BY SERPINB3 IN A TRANSGENIC MOUSE MODEL 49
PRO-ONCOGENIC EFFECT OF SQUAMOUS CELL CARCINOMA ANTIGEN VIA WNT/BETA-CATENIN SIGNALING 49
DOWNREGULATION OF SURFACE SQUAMOUS CELL CARCINOMA ANTIGEN EXPRESSION AND CD27+ MOLECULE ON B LYMPHOCYTES IN PATIENTS WITH CHRONIC HEPATITIS C 49
CELLULE PROGENITRICI EPATICHE ESPRIMONO SERPINB3 IN UN MODELLO MURINO DI EPATITE FULMINANTE 47
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma 47
1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2 46
ESPRESSIONE DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E CELLULE B DELLA MEMORIA IN CORSO DI INFEZIONE DA VIRUS DELL’EPATITE C 45
COMPORTAMENTO DI SCCA-IgM NEL SIERO DI BAMBINI HBeAg POSITIVI SEGUITI NEL TEMPO 43
ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA 40
Hepatotropic viruses: new insights in pathogenesis and treatment 39
Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici 38
SERPINB3 AS A PRO-INFLAMMATORY MEDIATOR IN THE PROGRESSION OF EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE. 37
SERPINB3 AND TGF-BETA IN CHRONIC LIVER DISEASE 36
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE OF VIRAL ETIOLOGY 35
MODULAZIONE DEI LIVELLI DI IL-6 NELLA RIGENERAZIONE EPATICA DA PARTE DI SERPINB3 ED ESTROGENI. ANALISI IN UN MODELLO DI TOPO TRANSGENICO 35
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE 31
SERPINB3 UP-REGULATION BY HYPOXIA IN HEPG2 CELLS : A HIF-2ALPHA AND REDOX SENSITIVE EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 30
The Protease Activated Receptor 2 - CCAAT/Enhancer-Binding Protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of Non-Alcoholic Steatohepatitis 16
Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo 16
SerpinB3 administration protects liver against ischemia-reperfusion injury 13
Inhibition of Protease-Activated Receptor-2 Activation in Parkinson’s Disease Using 1-Piperidin Propionic Acid 13
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition 13
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness 12
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation 10
1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition 9
Totale 5.381
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.396
article - articoli 17.464
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 175
selected - selezionate 0
volume - volumi 0
Totale 39.035
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020600 0 0 0 0 0 0 165 110 99 129 52 45
2020/2021743 29 36 23 35 24 65 20 39 101 173 98 100
2021/2022711 19 103 79 58 27 47 32 64 33 9 81 159
2022/2023885 140 88 18 96 153 146 0 79 107 6 38 14
2023/2024457 14 65 67 29 49 67 39 17 10 18 35 47
2024/2025711 10 202 75 99 212 67 46 0 0 0 0 0
Totale 5.381